Examination of inaccuracies and inequities in blood pressure measurement across office, ambulatory, home, and emerging cuffless modalities contribute to disparities in hypertension diagnosis and control, and strategies to improve measurement equity are identified.
Abstract
We aimed to examine how inaccuracies and inequities in blood pressure (BP) measurement across office, ambulatory, home, and emerging cuffless modalities contribute to disparities in hypertension diagnosis and control, and to identify strategies to improve measurement equity. Disparities arise from nonstandardized office technique, inappropriate cuff sizing, limited access to validated home and ambulatory devices, reimbursement and implementation barriers, and underrecognition of masked and nocturnal hypertension in populations at higher risk. Cuffless technologies may expand access and reduce cuff-related barriers, but current devices have important limitations in validation, calibration, real-world accuracy, and performance across diverse populations. Improving equity requires standardized measurement, access to appropriately sized validated devices and out-of-office monitoring, inclusive device validation, and reimbursement and implementation strategies that reach underrepresented and under-resourced communities. Future research should test whether these approaches reduce diagnostic misclassification and improve BP control and cardiovascular outcomes across populations.
Patients with RH were enrolled in the 3-month RBPM program, which resulted in meaningful systolic BP changes, high medication adherence, and favorable patient satisfaction, and cellular-enabled BP monitors outperformed their Bluetooth-enabled counterparts in data transmission reliability.
K. Trinh, Brenda Martinez-Puente, Lilit Vardanyan et al.· JACC Case Reports· 0 citations
BACKGROUND
Recommendations for blood pressure (BP) measurement are poorly followed in clinical practice, possibly leading to inaccurate BP estimates.
OBJECTIVES
To assess the agreement between routine and standardized BPs, and the association between BP level and cardiovascular disease (CVD) for each measurement type...
O. Gastgivars, J. Ögren, B. Carlberg et al.· Journal of Internal Medicine· 0 citations
Hypertension and cardiovascular diseases (CVDs) are the major causes of death, hospital admissions, and disability in the middle-aged, and regular blood pressure (BP) measurement is one of the simplest and most effective public health interventions available. Yet we know that noninvasive BP (NIBP) devices, ostensibly c...
Branko G. Celler, Raisa Rudino, A. Argha· IEEE Transactions on Instrum...· 0 citations
Hypertension remains the leading modifiable contributor to cardiovascular disease worldwide, yet diagnosis, sustained treatment, and blood pressure (BP) control remain inadequate. This narrative review evaluates emerging therapeutics that are changing how hypertension is measured, phenotyped, treated, and organized. A...
Jonsi Tavethia, D. Gowda, Shubh Mehta et al.· Current problems in cardiolo...· 0 citations
BACKGROUND
Accurate home blood pressure (BP) monitoring depends on appropriate cuff sizing, but the prevalence and cost implications of extra-large cuff need among US adults with hypertension are unknown.
METHODS
Using pooled data from 2017-2023 National Health and Nutrition Examination Survey (NHANES) with survey we...
Sumit Sahoo, Tammy Brady, Benjamin Grobman et al.· American Journal of Hyperten...· 0 citations
ABPM improves the diagnostic classification of hypertension and reveals a high prevalence of discordant phenotypes and nocturnal blood pressure abnormalities, and wider use of ABPM may help optimize patient management in this setting.
N. Gaye, J. Mingou, Coumba Kaba et al.· Cardiology and Cardiovascula...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.